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Abstract
Evaluation of suspected biliary tract obstruction is a common clinical problem. Clinical data such as history, physical
examination, and laboratory tests can accurately identify up to 90% of patients whose jaundice is caused by extrahepatic
obstruction. However, complete assessment of extrahepatic obstruction often requires the use of various imaging modalities
to confirm the presence, level, and cause of obstruction, and to aid in treatment plan. In the present summary, the literature
on competing technologies including endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic
cholangiopancreatography (PTC), endoscopic ultrasound (EUS), intraductal ultrasonography (IDUS), magnetic resonance
cholangiopancreatography (MRCP), helical CT (hCT) and helical CT cholangiography (hCTC) with regards to diagnostic
performance characteristics, technical success, safety, and cost-effectiveness is reviewed. Patients with obstructive jaundice
secondary to choledocholithiasis or pancreaticobiliary malignancies are the primary focus of this review. Algorithms for
the management of suspected obstructive jaundice are put forward based on current evidence. Published data suggest
an increasing role for EUS and other noninvasive imaging techniques such as MRCP, and hCT following an initial
transabdominal ultrasound in the assessment of patients with suspected biliary obstruction to select candidates for
surgery or therapeutic ERCP. The management of patients with a suspected pancreaticobiliary condition ultimately is
dependent on local expertise, availability, cost, and the multidisciplinary collaboration between radiologists, surgeons, and
gastroenterologists.
Key Words: jaundice, cholestasis, choledocholithiasis, common bile duct neoplasms, cholangiocarcinoma, cholangiopancreato-
graphy, cholangiography, endosonography, magnetic resonance angiography, magnetic resonance imaging, CT, spiral CT,
ultrasonography, costs and cost analysis
Introduction
Evaluation of obstructive jaundice is a common
clinical problem. Often, the initial problem is to
distinguish between intrahepatic and extrahepatic
biliary obstruction. Choledocholithiasis and pancrea-
ticobiliary malignancies (pancreatic head cancer,
ampullary cancer, and cholangiocarcinoma) are the
most common causes of extrahepatic obstruction.
Less common causes include benign strictures,
chronic pancreatitis, metastatic nodes to the porta
hepatis, and primary sclerosing cholangitis. Many
studies have shown that clinical data such as history,
physical examination, and laboratory tests can accu-
rately identify up to 90% of patients whose jaundice is
caused by extrahepatic obstruction [121]. However,
complete assessment of extrahepatic obstruction often
requires the use of various imaging modalities to
confirm the presence, level, and cause of obstruction,
and to aid in treatment planning. Current technolo-
gies include transabdominal ultrasound (US), endo-
scopic retrograde cholangiopancreatography (ERCP),
transhepatic cholangiopancreatography (PTC), endo-
scopic ultrasound (EUS), magnetic resonance cho-
langiopancreatography (MRCP), helical CT (hCT),
and helical CT cholangiography (hCTC). With the
rapid advancement in imaging technology, there is
ISSN 1365-182X print/ISSN 1477-2574 online # 2006 Taylor & Francis
DOI: 10.1080/13651820600746867
Correspondence: Dr Frances Tse, 4W8, McMaster University Medical Centre, 1200 Main Street West, Hamilton, Ontario, Canada, L8N 3Z5. Tel: /1 905
521 2100, ext. 76732. Fax: /1 905 521 4958. E-mail: tsef@mcmaster.ca
HPB, 2006; 8: 409425
little consensus in the literature as to which imaging
modality is most appropriate for a given clinical
situation. This can lead to duplication of testing
with the possibility of increasing costs and delaying
diagnosis. Furthermore, newer modalities are often
being incorporated into practice before accurate
assessment of their cost-effectiveness has been com-
pleted.
The purpose of this article is to review competing
technologies in the evaluation of suspected extrahe-
patic obstruction with regard to diagnostic perfor-
mance characteristics, technical success, safety, and
cost-effectiveness. Patients with obstructive jaundice
secondary to common bile duct (CBD) stones or
pancreaticobiliary malignancies are the primary focus
of this review. The work-up of patients with suspected
intrahepatic cholestasis will not be addressed. Algo-
rithms for the management of suspected obstructive
jaundice due to CBD stones and pancreaticobiliary
malignancies are provided.
Methods
A systematic search was performed for relevant arti-
cles published in English language using MEDLINE
and PUBMED from 1966 to December 2003. The
search strategy included the key terms: cholestasis,
choledocholithiasis, pancreatic neoplasms, biliary tract
neoplasms, cholangiocarcinoma, ampulla of vater, cho-
langiography, endoscopic, intravenous, laparoscopic, in-
tra-operative, ultrasonography, magnetic resonance
imaging, computed tomography, spiral computed tomo-
graphy, surgery, complications, decision support techni-
ques, costs and cost analysis, cost-benefit analysis,
sensitivity and specificity, comparative study, and pro-
spective studies . Information was collected on test
performance characteristics (sensitivity, specificity,
negative and positive predictive values), with regards
to identifying the presence, level, and cause of biliary
obstruction. The technical success, safety and costs of
the various imaging modalities were also examined
where appropriate. Where appropriate, although be-
yond the scope of this narrative review, pertinent
issues relating to tissue diagnosis and therapy (since
some of the techniques described may be both
diagnostic and therapeutic) are briefly discussed.
Finally, based on the results of the literature search,
clinically relevant algorithms were constructed to
highlight the possible roles of new technologies in
the work-up of patients with suspected CBD stones or
pancreaticobiliary malignancies.
Current imaging technologies
Direct versus indirect imaging
The various imaging modalities can be classified into
either direct or indirect techniques [22]. The former
are more invasive, and include ERCP and PTC. They
carry a higher associated risk, but have the added
ability to sample tissue and perform therapeutic
maneuvers, such as biliary drainage with stenting or
stone removal. The main concern with these techni-
ques is the risk of pancreatitis and cholangitis as a
result of opacification of an obstructed biliary tree
that cannot be drained, with rare complications such
as perforation, bleeding or bile leak [2326]. Also,
direct techniques are limited to the evaluation of the
intrinsic biliary tract and cannot define the presence
of extrinsic compression of the biliary tree by
surrounding structures. Indirect techniques offer
lower procedural risk and may allow staging of
malignancies. New indirect modalities, such as
MRCP (with solid organ MR), EUS, and hCTC
(with hCT) offer improved imaging quality, while at
the same time maintaining a low risk profile. EUS has
some therapeutic potential in addition to the oppor-
tunity for biopsy and cytology, but because it requires
conscious sedation, it is the most invasive of the
indirect group of imaging technologies. Table I
summarizes the advantages and disadvantages of the
main techniques discussed.
Table I. Comparison of advantages and disadvantages of the main biliary imaging techniques.
Indirect Direct
Imaging modality US hCTC* MRCP$ EUS ERCP PTC
Portability /// / / // / /
Safety /// // /// // / /
Operator dependence /// / // /// // //
Low cost /// / / / / //
Staging of malignancy / /// /// /// / /
Tissue sampling / / / /// /// //
Therapy / / / / /// ///
US, transabdominal ultrasound; hCTC, helical CT cholangiography; MRCP, magnetic resonance cholangiopancreatography; EUS,
endoscopic ultrasound; ERCP, endoscopic retrograde cholangiopancreatography; PTC, transhepatic cholangiopancreatography.
*hCTC includes cholangiography that requires intravenous contrast administration that is excreted into the biliary tract.
$Includes abdominal MR.
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Transabdominal ultrasonography (US)
Transabdominal US (US) remains the initial imaging
test of choice in the evaluation of suspected biliary
obstruction because it is noninvasive, inexpensive,
and readily available [9,2734]. Dilated ducts are
usually taken as indirect evidence of biliary obstruc-
tion [9,32,33,3538]. The presence of normal ducts,
however, does not exclude obstruction [9,32,33,35
38]. This is mainly because, in certain cases, biliary
obstruction may not be accompanied by dilatation of
the CBD. Conversely, the CBD increases in diameter
in response to cholecystectomy and aging [3945].
Despite these exceptions, ductal dilatation remains
an excellent clue to biliary obstruction. Specifically,
US has been shown to be highly accurate (7898%)
for detecting extrahepatic obstruction [9,27,32,33,
36,46]. In conjunction with a concordant clinical
evaluation, US allows an accurate differentiation
between liver parenchymal disease and extrahepatic
obstruction (sensitivity 65%, specificity 92%, PPV
92%, NPV 98%) [8,47]. However, US is less
discriminating with respect to the level and cause
of obstruction, with reported accuracies ranging
between 2795% and 2388%, respectively [2932,
34,35,46,4850]. Also, the test performance of US is
variable in differentiating malignant from benign
causes of obstruction with an overall accuracy ranging
from 47% to 90% [2931,34,35,46,4851]]. In the
diagnosis of CBD stones, US exhibits poor test
performance at detecting CBD stones with sensitiv-
ities in the range of 2558% and specificities of
6891% [27,36,46,48,52,53]. Variable results are
also seen in the setting of pancreaticobiliary malig-
nancies, with sensitivities ranging from 5% for
ampullary to 6781% for pancreaticobiliary malig-
nancies [5459]. These data demonstrate that the
major limitation of US is in its inability to reliably
diagnose the level and cause of obstruction. Other
drawbacks of US are operator dependency and
suboptimal imaging of retroperitoneal structures due
to overlying bowel gas or obesity [60].
Endoscopic retrograde cholangio-pancreatogragraphy
(ERCP)
Endoscopic retrograde cholangio-pancreatography
(ERCP) is performed using a side-viewing duodeno-
scope, which allows an en face view of the ampulla.
An instrument channel in the duodenoscope enables
cannulation of the papilla and injection of contrast
into the biliary and pancreatic ducts to obtain
diagnostic images. Therapeutic interventions such as
sphincterotomy, stone extraction, stricture dilatation,
stent insertion, and tissue sampling can be performed
at the same time.
ERCP has traditionally been considered the gold
standard for imaging the biliary system, particularly
if therapeutic intervention is planned. It can demon-
strate the cause of biliary obstruction, and helps in
making a diagnosis based on the morphology of the
biliary and pancreatic ducts. In the evaluation of CBD
stones, Frey et al. [61] noted that ERCP had a
sensitivity of 90%, a specificity of 98%, and an
accuracy of 96%. Standard procedures, such as
sphincterotomy (ES) and balloon or basket stone
extraction, are successful in clearing CBD stones in
8590% of cases [6267]. For those patients in
whom standard techniques are unsuccessful, mechan-
ical lithotripsy will increase the success rate to more
than 90% [68,69], while the insertion of a biliary stent
is reserved for rare high-risk cases [7072].
ERCP also plays an important role in the diagnosis
and palliation of pancreaticobiliary tumors. Radio-
graphic findings may be suggestive of malignancy, but
a definitive diagnosis requires tissue sampling.
Although many patients are managed without histo-
logical confirmation, confirmation allows accurate
decision making with respect to patient management
options, including surgery, endoscopic stenting, che-
motherapy, or radiotherapy [73]. Common methods
of endoscopic tissue sampling including brush cytol-
ogy, endoscopic fine-needle aspiration (FNA), and
forceps biopsy have relatively low to moderate sensi-
tivity (2060%) but almost 100% specificity [7476].
Cancer detection rate may be increased by combining
at least two sampling methods [74,77]. Tissue sam-
pling sensitivity also varies according to the type of
tumor. Brush cytology and forceps biopsy have a
higher sensitivity for cholangiocarcinoma (44100%)
than for pancreatic cancer (3065%) [73,74,7784].
Forceps biopsy is the single best technique for the
diagnosis of ampullary tumors, with a cancer detec-
tion rate of 7788% [74]. More recently, a number of
newer technologies have been proposed [76]. Pallia-
tion of malignant obstruction can be achieved by
ERCP with biliary stent insertion (plastic or metal).
Randomized controlled trials have shown endoscopic
stent placement to be cost-effective compared with
surgery, and to enhance quality of life [8589].
ERCP combines the advantage of diagnosis of
biliary obstruction with possible therapeutic interven-
tion. Because of the ability to perform therapeutic
maneuvers, ERCP has become the intervention of
choice in the management of patients with CBD
stones, and in the palliative treatment of patients
with malignant biliary obstruction [9092]. The
drawbacks to ERCP include equipment cost, need
for conscious sedation, and high operator depen-
dency. Failure rate increases substantially for patients
with altered anatomy such as Billroth II gastrectomy
[9396]. Limitations of ERCP include reduced
sensitivity with small stones in a dilated bile duct,
failure to visualize stones because of inadequate
opacification of the biliary tree with contrast, and
difficulty in differentiating stones from air bubbles
[97,98]. These limitations may lead to increases in
procedure time, unnecessary sphincterotomy, and
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unnecessary instrumentation of the bile duct with
balloon catheters and basket. Visualization of the
biliary tree proximal to an obstructing lesion can be
difficult, and contrast injection above the site of
obstruction usually mandates biliary stent insertion
because of the risk of cholangitis [92]. Also, the low
yield of ERCP for cytology in malignant obstruction
often results in additional procedures (EUS-FNA,
CT-FNA, or operation) to make a tissue diagnosis of
cancer [73,74,7784,99]. Furthermore, staging in-
formation for pancreaticobiliary malignancies is very
difficult to obtain by ERCP [100,101]. Large pro-
spective series have found overall complication rates
of 510% and mortality rates of 0.020.5% after
diagnostic and therapeutic ERCP [2326]. The most
common complication is acute pancreatitis, occurring
in 5% of cases, and being moderate to severe in about
1% [2326,102]. Complication rates appear to have
decreased more recently owing to a more careful
selection of patients (at lower risk for complications),
and perhaps, the increased use of guidewires for
selective cannulation [103,104]. Because of its atten-
dant risks, and the availability of safer noninvasive
cholangiographic methods with comparable diagnos-
tic abilities, ERCP is evolving into a predominantly
therapeutic procedure [105].
Percutaneous transhepatic cholangiography (PTC)
PTC involves puncture of the liver with a 22-gauge
needle under fluoroscopic guidance to enter the
peripheral intrahepatic bile duct system above the
common hepatic duct [106108]. Contrast is then
injected to opacify the biliary tree and to identify
obstruction. The biliary tree can be successfully
visualized in close to 100% of patients with dilated
ducts, and in 6080% of patients with nondilated
ducts [106108]. PTC is considered, along with
ERCP, the gold standard by which all other imaging
modalities of the biliary tree are evaluated. It is
excellent at determining the level and cause of biliary
obstruction, as well as distinguishing benign from
malignant lesions, while being less costly than ERCP
[109,110]. It can also be applied therapeutically for
external drainage of obstructed ducts.
The overall rate for major complications is B/5%,
with a mortality rate of 0.1% [107,111]. Complica-
tions include bile leaks, bile peritonitis, hemobilia,
sepsis, intraperitoneal hemorrhage, intrahepatic fistu-
las, gallbladder puncture, pneumothorax, subphrenic/
subhepatic abscess, pseudoaneurysms, arteriovenous
shunts, and allergic reactions to contrast material
[106,112114]. In a randomized controlled trial
comparing ERCP to PTC in the management of
patients with malignant biliary obstruction, ERCP
was found to be superior to PTC because of a higher
success rate, and lower complication rate and mortal-
ity [115]. Currently, indications for PTC are few; it is
performed primarily in patients in whom ERCP has
failed or when altered anatomy (gastroenterostomy)
precludes accessing the ampulla [116]. It has also
been used as a therapeutic drainage procedure in
patients with unresectable hilar tumors or hepato-
lithiasis [117121].
Endoscopic ultrasonography (EUS)
EUS combines endoscopy and ultrasound to provide
high-resolution images of the pancreaticobiliary sys-
tem transgastrically or transduodenally using a water-
filled balloon system for acoustic coupling [122,123].
Echoendoscopes have frequencies in the 7.512 MHz
range, which gives a depth of penetration of 810 cm.
Tissue sampling in the form of EUS-guided fine-
needle aspirate (EUS-FNA) can also be performed.
EUS is very accurate in determining the cause of
extrahepatic obstruction with a sensitivity of 97% and
a specificity of 88% compared with the combined gold
standard of ERCP, intraoperative cholangiography
(IOC), and clinical-follow-up [124]. In particular,
EUS is very accurate in diagnosing CBD stones, with
a sensitivity of 95%, specificity of 98%, and an
accuracy of 96% [17,22,57,122,123,125131]. These
results are far superior to US (sensitivity 63%) and
CT (sensitivity 71%) [127], and are equivalent if not
superior to those of ERCP or MRCP [132]. EUS is
especially more accurate in detecting small stones or
stones within small caliber CBDs [127,133]. EUS has
also been shown to be excellent in distinguishing
among different types of malignant obstruction
[57,99,134136]. The reported accuracies for EUS-
FNA of pancreaticobiliary masses are over 80%, with
results better for pancreatic masses than for biliary
tumors [137144]. Many prospective studies have
shown EUS to be more sensitive (93100%) than all
other imaging modalities including CT (5377%),
US (5067%), MRI (5067%), and ERCP (90%)
in the detection of pancreatic tumors [5456,136,
145153]. The superiority of EUS becomes even
more evident for tumors B/3 cm [54,55,145,
149,150,152]. This is clinically relevant as patients
with small tumors are most likely to benefit from
surgical resection. Once a pancreatic mass is identi-
fied, accurate staging is crucial to identify patients
with locoregional disease that is amenable to surgical
resection, and to prevent unnecessary surgical ex-
ploration. EUS is highly accurate in determining the
T (6994%) and N staging (5480%) of pancreatic
tumors [54,136,147,148,148,154]. It is more accu-
rate (8795%) than CT (4175%) and angiography
(7579%) for detecting invasion of the portal vein,
splenic vein, and confluence of the portal vein and
superior mesenteric vein [55,155160]. It is not as
accurate, however, for detecting involvement of the
superior mesenteric vein and major arterial vessels
[156,159,160]. For the detection of ampullary tu-
mors, many prospective studies have shown EUS
(95100%) to be equivalent to ERCP, but more
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sensitive than CT (568%) and US (524%)
[57,57,59,158,161169]. Also, locoregional tumor
staging was more accurately assessed by EUS (72
82% for T stage, 4771% for N stage) than with any
other imaging modalities [57,57,59,158,161169].
The improved staging ability of EUS may allow
selection of patients with ampullary tumors who can
undergo local resection instead of pancreaticoduode-
nectomy [157,165]. With respect to cholangiocarci-
noma, EUS has not been proven to offer more
information than other imaging modalities.
There are many features that make EUS an
attractive procedure. It is less invasive than ERCP
[170], and is able to diagnose most causes of
obstructive jaundice such as pancreaticobiliary malig-
nancies and CBD stones [17,122,123,125131] with
the same or better accuracy than ERCP. This tech-
nology does not expose the patient to radiation or
contrast material. EUS-FNA can also provide a tissue
diagnosis and important staging information for
pancreaticobiliary malignancies. The limitations of
EUS include the high operator dependency with a
steep learning curve, equipment cost, unit availability,
the inability to provide an immediate therapeutic
solution, the need for conscious sedation, and a 2%
failure rate [126]. Visualization is limited to the
nearest 810 cm depth from the probe, and imaging
can be obscured by pneumobilia, stents, surgical clips,
calcifying pancreatitis, or a duodenal diverticulum
[171].
Intraductal ultrasonography (IDUS)
IDUS is a relatively new technology and is not
available at most centers. IDUS of the bile duct
is performed with a highly flexible, thin-caliber
(/2 mm), non-optic US probe that can be passed
through the working channel of a standard duodeno-
scope and introduced into the biliary and pancreatic
ducts during ERCP. Acoustic coupling is optimized
by filling both ducts with fluid. IDUS images at higher
frequencies (1230 MHz) than standard EUS and
therefore provides higher resolution (0.070.18 mm),
but the depth of penetration is consequently reduced
(23 cm) [172]. Compared to standard EUS, IDUS
provides a better evaluation of the proximal biliary
system and surrounding structures such as the right
hepatic artery, portal vein, and contents of the
hepatoduodenal ligament [172176]. Use of wire-
guided IDUS probes allows biliary cannulation in
nearly 100% of patients without sphincterotomy
[177,178]. However, it may be necessary to dilate
severely stenotic lesions to facilitate passage of the
probe [177,178].
In the evaluation of biliary obstruction, IDUS as an
adjunct to ERCP and tissue sampling has been shown
to improve the ability to distinguish malignant from
benign strictures with a high degree of accuracy
(/90%) [173176,178190]. Furthermore, when
ERCP-guided bile duct biopsy fails to demonstrate
malignancy, the presence of certain IDUS sono-
graphic criteria such as a sessile tumor, tumor size
/10 mm, and an interrupted wall structure can more
favor a diagnosis of malignancy [184]. In a prospec-
tive study by Menzel et al., IDUS was more accurate
than EUS for determination of the nature of bile duct
strictures (89% vs 76%) and for T staging (78% vs
54%), particularly for tumors located at the bifurca-
tion and mid-bile duct [185]. However, N staging
with IDUS was inferior [185]. For the diagnosis and
T staging of ampullary tumors, IDUS was found to be
superior to EUS (100% and 88.9%, 59.3% and
56.3%, respectively) in a prospective study using
histopathology as gold standard [191]. For the
diagnosis of pancreatic cancer, preliminary studies
suggest that IDUS may be useful in detecting
carcinoma in situ and small tumors and in assessing
parenchymal invasion and the intraductal spread of
the tumor [150,192,193]. However, the tortuosity of
the pancreatic duct often precludes passage of the
probe to the proximal duct [194]. For the diagnosis of
CBD stones, IDUS seems to be more accurate than
ERCP in the detection of small stones within a dilated
duct and can differentiate stones from air bubbles
[195198].
IDUS has several advantages over EUS of the bile
duct, including higher resolution and the ability to
image the proximal bile ducts. Complications are
rare [176,194]. The drawbacks of IDUS include
high equipment cost, fragility of the probe, low
depth of penetration, and operator expertise. IDUS
is of limited value in assessing lymph nodes,
and cannot provide a histopathological diagnosis.
Stent-related changes of the bile duct wall may
reduce the diagnostic utility of IDUS [199201].
More studies are therefore needed to clearly define
the role, utility, and cost-effectiveness of IDUS in
the evaluation of patients with selected pancreatico-
biliary diseases. Depending on local availability,
expertise, and competing technologies, IDUS may
be considered in the work-up of patients with biliary
obstruction. A combination approach, using infor-
mation from IDUS, EUS, and ERCP may prove to
be ideal.
Magnetic resonance cholangio-pancreatography (MRCP)
Magnetic resonance cholangio-pancreatography
(MRCP) is performed with high resolution heavily
T2-weighted sequences to enhance the signal of
stationary fluids in the biliary and pancreatic ducts
without the use of contrast material or ionizing
radiation [202205]. Multiple images are generated
and reconstructed by a computer providing a three-
dimensional image of the bile ducts. Current techni-
ques permit imaging of the entire biliary tract in
a single breath-hold of 20 s or less and provide
high spatial resolution so that structures such as
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fourth-order intrahepatic bile ducts are easily visua-
lized in many cases [206208].
A recent authoritative meta-analysis [209] of 67
published controlled trials showed that MRCP has
excellent overall sensitivity (95%: 95% CI (75,99))
and specificity (97%: 95% CI (86,99)) for demon-
strating the level and presence of biliary obstruction.
However, MRCP is less sensitive for detecting stones
(91%: 95% CI (73,97)) [209]. Moreover, the sensi-
tivity for detecting stones seems to decrease accord-
ing to stone size: 67100% for stones /10 mm
in size, 8994% for stones measuring 610 mm,
and 3371% for bile duct stones B/6 mm in size
[210213]. Therefore, there may still be a need
for additional non-invasive or invasive imaging
methods when choledocholithiasis is suspected.
Also, MRCP is not reliable for differentiating malig-
nant from benign obstruction (88%: 95% CI
(70,96)) [209].
MRCP is very useful in the diagnosis of cholan-
giocarcinoma by identifying the exact location,
extent, and severity of the obstruction [214218].
Complete staging information of tumor size, bile
duct involvement, and vascular invasion can be
obtained when MRCP is combined with conven-
tional MRI and MR angiography (MRA) [215]. In
so doing, MRCP can evaluate the appropriateness of
curative surgical resection versus palliative drainage
procedures, and help determine whether PTC or
ERCP constitutes the most appropriate therapeutic
intervention [215,218,219]. For pancreatic cancer, a
large prospective controlled study found MRCP to
be as sensitive (84%) as ERCP in detecting pan-
creatic cancer associated with ductal dilatation
[220]. However, the detection of pancreatic cancer
by MRCP alone without ductal dilatation is difficult
[221225]. Ampullary lesions may be missed be-
cause of the poor performance of MRCP at or near
the duodenal wall as a result of interference from
intraluminal gas [226]. Also, MRCP does not
provide adequate information on staging and resect-
ability. The combinations of MRCP with conven-
tional MRI and MRA may provide sufficient ductal,
parenchymal, and vascular information for the
diagnosis and resectability of pancreatic cancers
[221225].
The major advantage of MRCP is the noninvasive
nature of the procedure. It does not require conscious
sedation, intravenous contrast, or radiation exposure.
Diagnostic images can be obtained in the vast
majority of patients including those who have com-
plex bilio-enteric anastomoses [227]. As well, MRCP
can demonstrate the biliary tree above and below a
complete obstruction [203]. In cholangiocarcinoma,
the main advantage of MRCP is that it can noninva-
sively provide a three-dimensional understanding of
the biliary tree, which can help in planning treatment
[218]. The major disadvantages of MRCP compared
with ERCP are lower spatial resolution, unit avail-
ability, lack of an immediate therapy that can be
provided for duct obstruction, claustrophobia, and
the inability to evaluate patients with pacemakers or
ferromagnetic implants [228]. Causes of possible
artifacts include pneumobilia, normal vessels, flow
artifacts, and duodenal diverticulum [229231]. A
stone impacted at the ampulla may be missed [232].
As well, low insertion of the cystic duct may be
mistaken for a dilated CBD [226], and clips in the
abdomen from previous surgery may distort images
[233].
Helical CT (hCT) and helical CT cholangiography
(hCTC)
hCTC uses slip ring technology with oral or intrave-
nous contrast to acquire volumetric data in a single
breath-hold for high-quality three-dimensional recon-
structions of the acquired image [2,4,203,234240].
It has the ability to opacify up to third-order intrahe-
patic bile ducts, and evaluate extra-ductal structures
in different phases (arterial, portal, parenchymal)
[241,242].
The accuracy of conventional CT in determining
the presence and level of obstruction has been 81
94% and 8892%, respectively [9,29,46,242245].
In the majority of cases, conventional CT can also
determine the cause of obstruction with a high degree
of accuracy (7094%) [4,29,53,234,244]. There are
only a few studies published on the use of hCTC
[24,214,235]. In a prospective study involving 131
patients with suspected biliary obstruction, hCTC
had an overall diagnostic accuracy of 93% in differ-
entiating benign from malignant causes of biliary
obstruction [214]. For the diagnosis of CBD stones,
hCTC achieved a sensitivity of 87% (95% CI
(84,90)), a specificity of 97% (95% CI (95,98)),
and an overall accuracy of 95% (95% CI (94,97)) for
the diagnosis of CBD stones compared to direct
imaging such as ERCP or IOC [3,4,235,237
242,246]. For the diagnosis and determination of
resectability of pancreatic cancer, a recent meta-
analysis of 68 controlled trials showed that hCT has
significantly higher accuracy (sensitivity 91% and
specificity 81%) than conventional US (sensitivity
82% and specificity 75%), or MRI (sensitivity 84%
and specificity 76%) [247]. For the diagnosis and
locoregional staging of peri-ampullary tumors, many
prospective studies have shown CT to be unreliable
(detection rates of 2229%) and less accurate than
EUS [59,157,158,162,166,167,191]. With regards
to the diagnosis of cholangiocarcinoma, hCT has
been shown to display accuracies up to 100% in
hepatic arterial dominant phase and 86% in portal
vein dominant phase scans [248]. However, hCT
is inaccurate for assessing resectability (6086%),
because of its limitations in detecting small perito-
neal implants, small hepatic metastasis, lymph node
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metastasis in normal sized nodes, and the intraductal
extent of tumor [248250].
The major advantages of hCTC over ERCP or
EUS include its low level of invasiveness, operator
independence, and low technical failure rate (1%), as
well as, in contrast to ERCP, a three-dimensional
understanding of the biliary tree. Although noninva-
sive, hCTC gives a relatively high dose of radiation
to patients. The major drawback of hCTC is a risk
of adverse reaction to the iodinated contrast agents
(1%). Major reactions include hepatorenal toxicity,
cardiopulmonary symptoms, hypotension, severe
skin reactions, and anaphylaxis [113]. Minor reac-
tions have been reported in up to 24% of patients
[113]. These include urticaria, pruritus, and gastro-
intestinal symptoms. The overall mortality rate is
1 in 30005000 examinations [113]. Its main limita-
tion is in patients with high-grade obstruction
and impaired hepatic function with high serum
bilirubin levels (/35 mmol/L) because contrast is
not eliminated sufficiently into the biliary tree
[237,238]. The artifacts produced by a patient’s
movement or respiration might also limit the diag-
nostic value of this test.
Algorithmic approach to patients with suspected
biliary obstruction
None of the aforementioned technologies are ideal,
and each exhibits advantages and disadvantages.
The optimal method of biliary imaging for the
diagnosis and management of patients with biliary
obstruction depends on the clinical situation.
Although every patient is different, general guide-
lines, based on diagnostic test performance of the
different imaging modalities, may be put forward in
the form of management algorithms. It must be
emphasized, however, that any final management
decisions for a given patient must be based on the
pre-test probability of a given condition (based on
history, physical examination, and laboratory data),
patient preferences, local availability of equipment,
and expertise. We attempt below to provide broad
guidelines in the work-up of patients with suspected
biliary obstruction.
The initial imaging test in patients with suspected
biliary obstruction should be a transabdominal
ultrasound. It is inexpensive, easy to perform,
readily available, and noninvasive. It has been
shown to be excellent for determining the presence
Suspected CBD stones 
Likelihood of CBD stone based on history, 
physical examination, lab data, and US 
Low HighIntermediate 
Laparoscopic
cholecystectomy 
No bile duct imaging 
Laparoscopic
intraoperative 
cholangiography 
Preoperative ERCP* or 
EUS* or 
MRCP*
Preoperative
ERCP
(in certain cases 
postoperative ERCP) OR*
Laparoscopic CBD 
exploration
Positive
OR*
Postoperative ERCP 
Figure 1. A proposed algorithm for the management of patients with suspected common bile duct (CBD) stones undergoing laparoscopic
cholecystectomy. ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; MRCP, magnetic resonance
cholangiopancreatography; US, transabdominal ultrasound. *Depending on costs, availability, and local expertise.
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or absence of bile duct obstruction, although it is
not as good for determining the level or the cause
of the obstruction. Ultrasound results will help
determine the next imaging study to perform, if
any.
Biliary obstruction  suspected CBD stones
Proper selection of patients for further biliary imaging
to exclude CBD stones is crucial in order to minimize
patient morbidity and institutional costs. Many deci-
sion models have confirmed that an optimal approach
to the management of these patients is dependent on
the pre-test probability of having CBD stones, as well
as local availability and expertise [1,1021]. A full
discussion of all predictive models is beyond the scope
of this review. For patients at low risk of CBD stones,
laparoscopic cholecystectomy should be performed
with no cholangiography. ERCP remains the pre-
ferred procedure (either preoperatively or postopera-
tively) for patients at high risk of CBD stones. For
patients at intermediate risk of CBD stones, the
optimal approach seems to be intraoperative cholan-
giogram followed, if positive, by laparoscopic CBD
exploration or postoperative ERCP depending on
local expertise. Alternatively, a strategy that involves
preoperative ERCP, EUS, or MRCP may be consid-
ered for patients at intermediate risk, depending on
local availability, expertise, and cost issues. A pro-
posed algorithm for the management of patients with
suspected CBD stones undergoing laparoscopic cho-
lecystectomy is shown in Figure 1 [22]. In the
postoperative setting, the optimal approach is again
dependent on the pre-test probability of CBD stones.
Suspected pancreaticobiliary 
malignancy based on history, physical 
examination, lab data, and US 
Suspected level of obstruction based on 
US
Upper third of 
CBD
Lower third 
of CBD 
Middle third of 
CBD
MRCP* or 
EUS* or 
hCTC* or 
ERCP*
MRCP*
or hCTC* 
Surgery
Surgical candidate and 
lesion appears resectable 
Yes
Palliative treatment 
that may include 
ERCP with stenting 
Level
indeterminate 
EUS* or 
MRCP* or 
hCTC*
EUS *or 
ERCP*
EUS-FNA* 
No specific cause Specific cause determined 
Re-evaluate
Further imaging 
No
Diagnosis
and staging 
modalities 
Figure 2. A proposed algorithm for the management of patients with suspected pancreaticobiliary malignancy. CBD, common bile duct;
ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; FNA, fine-needle aspiration; hCTC, helical CT
cholangiography; MRCP, magnetic resonance cholangiopancreatography; US, ultrasound. *Depending on costs, availability, and local
expertise.
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PTC can be used as an alternative to surgery in
patients with failed ERCP who require urgent biliary
drainage, such as in undrained cholangitis. hCTC
cannot be recommended in the routine work-up and
management of patients with suspected CBD stones
because of its risks and limited performance char-
acteristics in patients with high grade obstruction.
Biliary obstruction  suspected pancreaticobiliary
malignancy
If pancreaticobiliary malignancy is suspected on the
basis of clinical and US findings, further imaging
must be performed to obtain a diagnosis, stage the
extent of the malignant process for resectability, and
evaluate the need for possible palliative treatment.
Identification of the level of obstruction is of great
importance since the differential diagnosis and ther-
apeutic implications are different for each level. A
distal CBD obstruction may be amenable to an
endoscopic or surgical drainage procedure whereas a
more proximal one may require a more complex
intrahepatic anastomosis or percutaneous drainage.
The optimal approach to patients with malignant
biliary obstruction must take into account the perfor-
mance characteristics of the different imaging mod-
alities, the level and cause of the obstruction, the risk
of cholangitis when opacifying an obstructed biliary
tree, and the potential for curative versus palliative
therapy. Recent data suggest that noninvasive biliary
imaging may greatly assist endoscopic drainage and
diminish septic complications that occur when there is
a failed attempt at unilateral or bilateral drainage
[215,216,218,251,252]. A proposed algorithm for the
management of patients with suspected pancreatico-
biliary malignancy is shown in Figure 2, and presents
many similarities to that recently proposed by the
ASGE [253].
Decision models, cost-effectiveness and
outcome studies
The literature with respect to cost-effectiveness of the
new biliary imaging technologies is unfortunately
limited. In a decision analysis, the use of MRCP to
guide unilateral biliary stent placement in a patient
with inoperable hilar obstruction reduces the overall
cost of treatment by $469 per patient [254]. However,
the uncertainty of any survival advantage that bilateral
biliary stent placement conferred over unilateral stent
placement makes cost-effectiveness difficult to assess.
Another decision analysis model found that EUS was
the least costly method to evaluate possible CBD
stones before laparoscopic cholecystectomy unless its
accuracy dropped below 90% and the cost rose above
6070% that of ERCP [255]. Other cost-effectiveness
analyses also favor EUS-FNA in the diagnosis and
staging of pancreatic cancer by minimizing the
number of unnecessary surgical explorations, avoiding
the need for further diagnostic tests while influencing
clinical decisions [256259].
Real-life results, however, may be different from
what could be anticipated on the basis of test
performance characteristics or decision modeling.
For example, coincident with the marked increase in
the number of MRCPs performed for biliary obstruc-
tion at the Hopital Erasme in Brussels from 1995 to
1997, there was only a minor reduction in the total
number of ERCPs (about one diagnostic or thera-
peutic ERCP less for every four additional MRCPs)
[260]. Preliminary data from a prospective rando-
mized trial [261] from our group comparing ERCP
with MRCP, whose study population was mainly
composed of patients with suspected choledocho-
lithiasis, suggested a high rate of subsequent ERCPs
in the MRCP arm (51%), with no differences between
the groups in terms of rate of subsequent complica-
tions or overall duration of hospital stay. In a
prospective study, performing EUS-FNA as the first
endoscopic procedure in patients suspected to have
biliary obstruction obviated the need for about 50% of
ERCPs, helped direct subsequent therapeutic ERCP,
and substantially reduced costs by $3513 per patient
[262]. Similarly, in a selected cohort of 44 patients
with pancreatic cancer, EUS-FNA may have avoided
unnecessary surgery in 27% and further diagnostic
testing in 57% for a saving of $3300 per patient [140].
More true outcome trials are therefore needed to
better assess the impact on clinical decision-making or
patient outcomes of these new diagnostic methods.
Conclusion
In summary, published data suggest an increasing role
for EUS and other noninvasive imaging techniques
such as MRCP and hCT following an initial US in the
assessment of patients with suspected biliary obstruc-
tion to select candidates for surgery or therapeutic
ERCP. Ultimately, the management of patients with a
suspected pancreaticobiliary condition is dependent
on local expertise, availability, cost, and collegial
multidisciplinary collaboration between radiologists,
surgeons, and gastroenterologists.
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